Michał Sebastian Bochenek

Mr. Michał Sebastian Bochenek

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2024 in Applied Sciences
Verified
Journal Article
Open access
PDF file
MBMichał Sebastian Bochenek
Michał Sebastian Bochenek
JTJan Tomasik
Jan Tomasik
AWAndrzej Wędrychowicz
Andrzej Wędrychowicz
PTPrzemyslaw Tomasik
Przemyslaw Tomasik
Background: An increasing number of people around the world suffer from Crohn’s disease (CD), one of the inflammatory bowel diseases (IBDs). Recent evidence suggests that the endogenous cannabinoid system plays an important role in IBD. The main endocannabinoids, anandamide (AEA) and 2-arachidonoylglycerol (2-AG), are ligands of the CB1 and CB2 receptors that are expressed on immune cells. These receptors as well as endocannabinoids are believed to mediate inflammatory activity and participate in the pathophysiology of CD. Objective: Very little is known about the secretion of endogenous cannabinoids throughout the course of CD. Therefore, the aim of this study was to determine and analyze the 2-AG and AEA concentrations in children who suffered from CD. Methods: We studied 34 adolescents with CD, mean age 13.5 years ± 2.0. Blood samples were collected three times in the active phase of the disease (during admission to hospital, before treatment), 2–4 weeks later, during the treatment and clinical improvement of the patients, and 3–6 months later, in the period of remission. The control group included 33 healthy teenagers of the same age who were examined once. In all patients, fasting blood samples were collected in the morning. 2AG and AEA concentrations in serum were measured using EIA kits (Abclonal, Woburn, MA, USA and ELK Biotechnology Co., Ltd. Wuhan, China, respectively). Results: The median 2-AG concentration in the study group was stable: acute phase 907.4 [379.3; 1300.5] pg/mL, during treatment 715.1 [416.7; 1302.5] pg/mL; remission 991.1 [381.1; 1652.5] pg/mL, and similar to the values observed in the control group 761.8 [504.3; 1497.0] pg/mL. No significant differences were found between the results obtained at all time points in the study group and compared to the control group (in all cases p > 0.44). In the case of AEA, in the study group before treatment, the median concentration was 2.63 [2.24; 2.79] ng/mL and similar to values obtained during treatment 2.56 [2.33; 3.06] ng/mL, and in remission, with 2.61 [2.46; 2.85] ng/mL. All these concentrations were lower compared to the values measured in the control group of 3.18 [2.57; 3.88] ng/mL (p = 0.023, p = 0.035, p = 0.056, respectively). Conclusions: While 2-AG levels remained stable throughout the disease course and were comparable to controls, AEA concentrations were consistently lower in CD patients. Therefore, therapeutic interventions aimed at increasing AEA-related signaling, such as administration of its analogues or fatty acid amide hydrolase inhibitors, may improve symptoms associated with Crohn’s disease in children.

24 April 2026 in Medical Science Pulse
Verified
Journal Article
Closed access
DWDaria Kinga Wańczyk
Daria Kinga Wańczyk
KFKinga Filip
Kinga Filip
MBMichał Sebastian Bochenek
Michał Sebastian Bochenek
WJWojciech Franciszek Jakubowski
Wojciech Franciszek Jakubowski
SKSylwia Wiktoria Kolano
Sylwia Wiktoria Kolano
MDMikołaj Dubiel
Mikołaj Dubiel
Background: Dental anxiety is a common phenomenon among children and frequently leads to avoidance of dental visits, reduced cooperation during procedures, and deterioration of oral health. A lack of cooperation poses significant challenges for clinicians, affecting the course, duration, and overall effectiveness of treatment. Early identification and appropriate management of anxiety and pain are therefore essential to ensure successful dental care and to promote positive oral health behaviors later in life.Aim of the study: The aim of this systematic review is to summarize the available methods for reducing anxiety and pain in pediatric dentistry.Material and methods: This systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The review protocol was developed a priori and defined the research question, eligibility criteria, data sources, search strategy, record management procedures, and methods of data synthesis.Results: Over the years, numerous strategies have been developed in pediatric dentistry to address these concerns, including both non-pharmacological and pharmacological approaches. Behavioral and communicative techniques, as well as various distraction methods such as audiovisual aids, virtual reality, and music therapy, are widely used to support anxious children and improve their experience in the dental setting. Relaxation strategies and parental involvement further contribute to enhancing patient comfort and reducing procedural distress.When behavioral approaches are insufficient, sedation or general anesthesia may be employed to facilitate safe and effective treatment, ensuring that necessary procedures can be completed without compromising the quality of care. Recent advances also include the introduction of modern digital tools and child-friendly technologies designed to create a supportive and engaging dental environment.Conclusions: This review summarizes current methods for reducing anxiety and pain in children undergoing dental treatment and highlights emerging developments aimed at improving patient experience and overall clinical outcomes.

2 March 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
SKSylwia Wiktoria Kolano
Sylwia Wiktoria Kolano
MDMikołaj Dubiel
Mikołaj Dubiel
MBMichał Sebastian Bochenek
Michał Sebastian Bochenek
WJWojciech Jakubowski
Wojciech Jakubowski
JTJan Tomasik
Jan Tomasik
AGAleksandra Gródek
Aleksandra Gródek
Vitamin K antagonists (VKAs) remain essential in the management of patients with mechanical heart valves, rheumatic mitral stenosis, and selected cases of atrial fibrillation. Because therapeutic effectiveness depends on maintaining the international normalized ratio (INR) within a narrow target range, strategies that improve INR stability are critical to reducing the risks of thromboembolic and hemorrhagic complications. Traditional clinic-based monitoring is limited by infrequent testing and delayed dose adjustments, prompting growing interest in patient self-testing (PST) and patient self-management (PSM). This review assessed the impact of PST and PSM on anticoagulation quality and clinical outcomes in adults treated with VKAs. A targeted PubMed search (2015–2025) identified meta-analyses and randomized controlled trial evaluating INR self-monitoring. Three high-quality sources—a Cochrane review, a network meta-analysis, and a meta-analysis focused on telemedicine-supported PST—served as the primary evidence base. Across studies, both PST and PSM significantly increased time in therapeutic range (TTR), typically by 5–10 percentage points compared with standard care. PSM and telemedicine-assisted PST demonstrated the greatest improvements. Enhanced TTR translated into reductions in thromboembolic events, particularly in high-intensity PSM strategies. Importantly, no increase in major bleeding was observed in any self-monitoring model, indicating a favorable safety profile. In conclusion, INR self-monitoring, especially intensive PSM and telemedicine-enabled PST, offers an effective and safe approach to improving anticoagulation control in patients requiring long-term VKA therapy. These strategies address well-recognized limitations of traditional INR monitoring and support more responsive, patient-centered care.

2 July 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
POPatryk Obajtek
Patryk Obajtek
SSSylwia Sanakiewicz
Sylwia Sanakiewicz
MDMikołaj Dubiel
Mikołaj Dubiel
MBMichał Sebastian Bochenek
Michał Sebastian Bochenek
Background and Objectives: This narrative review aims to evaluate the systemic challenges in managing Chronic Low Back Pain (CLBP) and establish an evidence-based operational framework for primary care. Methods: Utilizing data synthesized from landmark epidemiological reports, functional neuroimaging studies, and guidelines from the National Institute for Health and Care Excellence (NICE) and the American College of Physicians (ACP), the analysis focused on diagnostic triage, routine imaging stewardship, and the neurobiology of pain chronicity. Findings: Findings indicate that the traditional biomedical model drives an "iatrogenic paradox," where over-medicalization and premature imaging induce a nocebo-driven labeling effect, worsening long-term disability. True chronicity is predominantly mediated by central sensitization, nociplastic pathways, and psychosocial yellow flags rather than structural spinal abnormalities. Consequently, clinical assessment must prioritize a "three-bucket" diagnostic triage and validated risk stratification over incidental pathoanatomical findings. Conclusions: Addressing the escalating global burden of CLBP requires a decisive paradigm shift toward a biopsychosocial, stepped-care model. Primary care physicians must act as rigorous gatekeepers against low-value medicalization, instead prioritizing patient education, early reassurance, and active, tailored exercise therapy. Future strategies should emphasize clinical phenotyping and implementation science to effectively bridge the gap between research evidence and routine primary care practice.

3 November 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
MMMargherita Moncada
Margherita Moncada
MSMartina Lo Sterzo
Martina Lo Sterzo
LPLUCA PALAZZESE
LUCA PALAZZESE
FBFrancesca Boffa
Francesca Boffa
DADebora Agata Anzalone
Debora Agata Anzalone
PLPasqualino Loi
Pasqualino Loi
Dry storage at room temperature (RT) could simplify spermatozoa banking. Here, we explored DNA stability and in vitro and in vivo development of embryos derived from vacuum-dried encapsulated (VDE) ram spermatozoa stored for four years or after accelerated aging. While some genomic damage was detected at time 0, DNA fragmentation increased from 3.32±3% (time 0) to 37.64±4% (4 years). A decrease in blastocyst rate was observed after four years of storage and 6.7 years of simulated storage (10.2% and 9% versus 13.16% at time 0). Embryo quality, assessed based on Cdx2 and Inf-τ gene expression, declined over time. Only two of the 23 embryos transferred into synchronized ewes were implanted but were lost by day 40. In conclusion, dry spermatozoa generated blastocysts after four years of RT storage, but their post-implantation development was impaired. Optimization of the water extraction and storage conditions could better preserve the spermatozoa’s DNA integrity, resulting in improved embryo quality, compatible with development to term.

6 October 2026 in Acta Oto-Laryngologica Case Reports
Verified
Journal Article
Open access
ALAnna Teresa Lato
Anna Teresa Lato
JMJulia Miaśkiewicz
Julia Miaśkiewicz
MBMichał Sebastian Bochenek
Michał Sebastian Bochenek
JTJerzy Tomik
Jerzy Tomik
ASAleksandra Sucherska
Aleksandra Sucherska
1. Myxoid/round cell liposarcoma (MRCLS), currently classified as high-grade myxoid liposarcoma (MLS), is a major subtype of soft tissue sarcoma in adults, commonly affecting the extremities, parti...